Two experts share key takeaways from one of the most important congenital heart surgery trials of the past decade.
Thomas E. Fagan, MD, joined Cleveland Clinic Children’s as Director of Pediatric and Congenital Cardiac Catheterization Laboratory in 2018. He sat down with CQD to discuss the team’s approach to congenital heart disease.
In congenital heart surgery, experience begets innovation. Successful development of a novel trans-conal unroofing approach to a rare heart defect is a case in point.